Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 154 of 1,261

  1. US 11833130

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  2. US 11833159

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  3. US 11834441

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  4. US 11833221

    Oligomeric compounds for reducing DMPK expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  5. US 11833205

    Kaolinite composite diagnostic and therapeutic agent and preparation method and use thereof

    China University of Geosciences · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11833157

    Precipitation resistant small molecule drug formulations

    XERIS PHARMACEUTICALS, INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  7. US 2023381101

    AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Nov 30, 2023 · Expires Nov 25, 2043

    granted

  8. US 11827685

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  9. US 11826407

    Peptide conjugated particles

    Northwestern University · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  10. US 11826325

    Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection

    The First Affiliated Hospital of Xi'an Jiaotong University · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  11. US 11826464

    Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  12. US 11826429

    Pharmaceutical composition comprising brinzolamide

    SENTISS PHARMA PRIVATE LIMITED · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  13. US 11827601

    Heterocyclic NMDA antagonists

    Takeda Pharmaceutical Company Limited · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  14. US 11827637

    Azaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  15. US 11827678

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  16. US 11827627

    N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  17. US 11826386

    Compositions and methods for treating cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  18. US 11826491

    Compositions and methods for improving cardiac function

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  19. US 11827616

    Heterocyclic compounds as pesticides

    Discovery Purchaser Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  20. US 11827877

    Compositions and methods for genomic editing by insertion of donor polynucleotides

    CRISPR THERAPEUTICS AG · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  21. US 11827883

    Dosages and methods for delivering lipid formulated nucleic acid molecules

    Alnylam Pharmaceuticals, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  22. US 11827683

    Bi-functional anti-tau polypeptides and use thereof

    REGENERATIVE RESEARCH FOUNDATION · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  23. US 11827687

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  24. US 11827900

    Engineered target specific nucleases

    Sangamo Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.